A mevalonate-independent pathway of isoprenoid biosynthesis present in Plasmodium falciparum was shown to represent an effective target for chemotherapy of malaria. This pathway includes 1-deoxy-D-xylulose 5-phosphate (DOXP) as a key metabolite. The presence of two genes encoding the enzymes DOXP synthase and DOXP reductoisomerase suggests that isoprenoid biosynthesis in P. falciparum depends on the DOXP pathway. This pathway is probably located in the apicoplast. The recombinant P. falciparum DOXP reductoisomerase was inhibited by fosmidomycin and its derivative, FR-900098. Both drugs suppressed the in vitro growth of multidrug-resistant P. falciparum strains. After therapy with these drugs, mice infected with the rodent malaria parasite P. vinckei were cured.
The gcpE and lytB gene products control the terminal steps of isoprenoid biosynthesis via the 2-C-methyl-D-erythritol 4-phosphate pathway in Escherichia coli. In lytB-deficient mutants, a highly immunogenic compound accumulates significantly, compared to wild-type E. coli, but is apparently absent in gcpE-deficient mutants. Here, this compound was purified from E. coli v vlytB mutants by preparative anion exchange chromatography, and identified by mass spectrometry, 1 H, 13 C and 31 P NMR spectroscopy, and NOESY analysis as (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP). HMB-PP is 10 4 times more potent in activating human VQ Q9/VN N2 T cells than isopentenyl pyrophosphate. ß
Human VQ Q9/VN N2 T cells play a crucial role in the immune response to microbial pathogens, yet their unconventional reactivity towards non-peptide antigens has been enigmatic until recently. The break-through in identi¢cation of the speci¢c activator was only possible due to recent success in a seemingly remote ¢eld: the elucidation of the reaction steps of the newly discovered 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway of isoprenoid biosynthesis that is utilised by many pathogenic bacteria. Unexpectedly, the intermediate of the MEP pathway, (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate) (HMB-PP), turned out to be by far the most potent VQ Q9/VN N2 T cell activator known, with an EC 50 of 0.1 nM. ß
In all organisms studied so far, isoprenoids such as dolichol, ubiquinones, carotenoids, and sterols are synthesized from isopentenyl diphosphate (IPP) and its isomer, dimethylallyl diphosphate (DMAPP). However, there are two completely different biosynthetic pathways leading to these two precursor molecules. In animals, fungi, archaea, and some bacteria, IPP and DMAPP are synthesized via the well-known mevalonate pathway. In contrast, the vast majority of bacteria, and some parasitic protozoa of the phylum Apicomplexa, synthesize IPP and DMAPP via the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway [also known as the 1-deoxy-D-xylulose-5-phosphate (DOXP), or non-mevalonate pathway]. [1][2][3] Since the MEP pathway is not used by humans, it represents an attractive target for the development of new antimicrobial compounds and indeed, inhibitors of the second enzyme of the MEP pathway, DOXP reductoisomerase, have demonstrated good antibacterial as well as antimalarial activity, in clinical settings. [4][5][6] Both IPP and DMAPP are formed (in a ~5:1 ratio) in the last step of the MEP pathway from the substrate (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) in the following reaction: catalyzed by the enzyme HMBPP reductase, also known as LytB or IspH. 7 The reaction is thought to involve an iron-sulfur cluster reducing HMBPP to an allylic anion, followed by protonation at either C2 or C4, to form IPP or DMAPP. 8 However, the three-dimensional structure of the LytB enzyme has not yet been reported, making mechanistic analyses more challenging. Here, we report the X-ray crystallographic structure of the LytB enzyme from Aquifex aeolicus and propose a structure-based model for catalysis.We first discuss several features of LytB sequences in general that might be expected to be of importance for substrate binding and catalysis by considering the sequence homology between 224 LytB enzymes as annotated by the JPRED3 program. 9 There are three totally conserved cysteines in the A. aeolicus sequence that anchor the catalytically active iron-sulfur cluster: Cys13, Cys96, and Cys193 (Figure 1 and Supporting Information, Figure S1). HMBPP can be expected to bind to the iron-sulfur cluster during catalysis via its O4 atom, but it also needs to bind to protein residues and related diphosphates typically bind to prenyl synthase enzymes either via a DDXXD motif or via electrostatic/hydrogen bond interactions with Lys, Arg, or His. On the basis of the sequence alignment (Supporting Information Figure S1) we find neither evidence for DDXXD clusters, consistent with the lack of a requirement for Mg 2+ , nor totally conserved Lys or Arg residues or even totally conserved Lys/Arg positions. There are, however, two highly conserved His residues, H42 and H124. These two conserved His were reported in 10 putative LytB sequences by Adam et al. 11 and are now seen in all 224 sequences. This strongly suggests that the diphosphate binds to H42 and H124. The third feature that would be expected for LytB is the presence of a totally...
Recombinant LytB protein from the thermophilic eubacterium Aquifex aeolicus produced in Escherichia coli was puri¢ed to apparent homogeneity. The puri¢ed LytB protein catalyzed the reduction of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) in a de¢ned in vitro system. The reaction products were identi¢ed as isopentenyl diphosphate and dimethylallyl diphosphate. A spectrophotometric assay was established to determine the steady-state kinetic parameters of LytB protein. The maximal speci¢c activity of 6.6 þ 0.3 W Wmol min 31 mg 31 protein was determined at pH 7.5 and 60 ‡C. The k cat value of the LytB protein was 3.7 þ 0.2 s 31 and the K m value for HMBPP was 590 þ 60 W WM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.